Articles

Myeloma-like approach shows early promise for rare plasma cell disorder...

Heather Landau, MD, Memorial Sloan Kettering Cancer Center, New York, NY,...

NXC-201 demonstrated organ responses in 70% of evaluable patients with relapsed/refractory...

Tanya Tucker is among the first patients in the U.S. to...

Initial early results were seen for the use of chimeric antigen...

For the first time, researchers in the U.S. have been able...

The retired Cleveland Clinic physician said years of practicing internal medicine...